West Liberty University’s Graphic Design students are again seeking nonprofits to partner with them for pro bono work to meet ...

For his part, Nix agrees: the more realistic and realizable use of AI is the streamlining of what he calls the “really ...

Renowned letterpress artist Alan Kitching is returning to his hometown of Darlington for a new exhibition titled "British ...

We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where Blueprint Medicines Corporation (NASDAQ:BPMC) stands against other top ...

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

Looking to further amp up its immunology business, Sanofi has agreed to acquire Blueprint Medicines in a deal that could be worth as much as $9.5 billion.. Blueprint’s research revolves around an ...

Sanofi is paying $129 per share in cash for Blueprint, amounting to a $9.1 billion equity value and a 27% premium on the biotech’s closing price on Friday.

Blueprint’s budget must go through two public hearings, starting with the Citizens Advisory Committee, which can hit the brakes before the Blueprint board rubber-stamps another bloated budget.

Gov. Wes Moore has enacted the first major update to Maryland’s lofty education reform plan since it became law in 2021, but he said during a recent bill-signing ceremony that the changes didn ...

Blueprint was prepared to spend $5,537,927 on the redesign. It is unclear where these funds will be shifted to now. The agency is still eager to work something out with FDOT if possible, but the ...

According to Harris, the Blueprint fund will be exhausted next year, leaving an $81 million deficit for the 2027 fiscal year. He said that if House Bill 504 and Senate Bill 429 were enacted, it ...